These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 6128373)

  • 21. Facilitation, augmentation and potentiation of transmitter release at frog neuromuscular junctions poisoned with botulinum toxin.
    Lupa MT; Tabti N
    Pflugers Arch; 1986 Jun; 406(6):636-40. PubMed ID: 2872654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polyneuronal innervation and quantal transmitter release in formamide-treated frog sartorius muscles.
    Herrera AA
    J Physiol; 1984 Oct; 355():267-80. PubMed ID: 6149312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modification by lithium of transmitter release at the neuromuscular junction of the frog.
    Branisteanu DD; Volle RL
    J Pharmacol Exp Ther; 1975 Aug; 194(2):362-72. PubMed ID: 239225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Augmentation: A process that acts to increase transmitter release at the frog neuromuscular junction.
    Magleby KL; Zengel JE
    J Physiol; 1976 May; 257(2):449-70. PubMed ID: 820854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcium dependence of evoked transmitter release at very low quantal contents at the frog neuromuscular junction.
    Andreu R; Barrett EF
    J Physiol; 1980 Nov; 308():79-97. PubMed ID: 6112267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long term changes in augmentation, potentiation, and depression of transmitter release as a function of repeated synaptic activity at the frog neuromuscular junction.
    Magleby KL; Zengel JE
    J Physiol; 1976 May; 257(2):471-94. PubMed ID: 820855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Barbiturates and transmitter release at the frog neuromuscular junction.
    Pincus JH; Insler NF
    Brain Res; 1981 May; 213(1):127-37. PubMed ID: 6113031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binomial analysis of quantal transmitter release at glycerol treated frog neuromuscular junctions.
    Miyamoto MD
    J Physiol; 1975 Aug; 250(1):121-42. PubMed ID: 240928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A statistical model supports the subunit hypothesis of quantal relsease.
    Matteson DR; Kreibel ME; Llados F
    Neurosci Lett; 1979 Dec; 15(2-3):147-52. PubMed ID: 43495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency and amplitude gradients of spontaneous release along the length of the frog neuromuscular junction.
    Robitaille R; Tremblay JP
    Synapse; 1989; 3(4):291-307. PubMed ID: 2568018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A method for testing an extended poisson hypothesis of spontaneous quantal transmitter release at neuromuscular junctions.
    Yana K; Takeuchi N; Takikawa Y; Shimomura M
    Biophys J; 1984 Sep; 46(3):323-30. PubMed ID: 6487732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Profiles of evoked release along the length of frog motor nerve terminals.
    D'Alonzo AJ; Grinnell AD
    J Physiol; 1985 Feb; 359():235-58. PubMed ID: 2860241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein phosphatase inhibitor okadaic acid enhances transmitter release at neuromuscular junctions.
    Abdul-Ghani M; Kravitz EA; Meiri H; Rahamimoff R
    Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1803-7. PubMed ID: 1672044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Facilitation, augmentation, and potentiation of transmitter release.
    Magleby KL
    Prog Brain Res; 1979; 49():175-82. PubMed ID: 42112
    [No Abstract]   [Full Text] [Related]  

  • 35. Dual action of meperidine on the frog neuromuscular junction: a prejunctional, opiate receptor-mediated depression of transmitter release and a postjunctional, nonopiate receptor effect on the endplate.
    Durham HD; Frank GB
    Arch Int Pharmacodyn Ther; 1981 May; 251(1):150-65. PubMed ID: 6114716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Binomial parameters of mediator release in the process of facilitation of neuromuscular transmission].
    Zefirov AL
    Neirofiziologiia; 1980; 12(3):314-6. PubMed ID: 6105625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution of spontaneous release along the frog neuromuscular junction.
    Tremblay JP; Robitaille R; Grenon G
    Neurosci Lett; 1984 Oct; 51(2):247-52. PubMed ID: 6151156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of muscle fiber activity on mediator release at frog neuromuscular synapses].
    Migulina EV; Minor AV
    Fiziol Zh SSSR Im I M Sechenova; 1980 Apr; 66(4):515-24. PubMed ID: 6104607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantal release and facilitation at frog neuromuscular junctions at about 0 degrees C.
    Molgó J; Van der Kloot W
    J Neurophysiol; 1991 Apr; 65(4):834-40. PubMed ID: 1675673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Equivalence of Ca2+ and Sr2+ in transmitter release from K+-depolarised nerve terminals.
    Mellow AM
    Nature; 1979 Nov; 282(5734):84-5. PubMed ID: 41184
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.